AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF STABILIZED 4-HYDROXYIFOSFAMIDE IN HUMAN PLASMA AND ERYTHROCYTES
Authors: KERBUSCH T HUITEMA ADR KETTENESVANDENBOSCH JJ KEIZER HJ OUWERKERK J DEKRAKER J BEIJNEN JH
Citation: T. Kerbusch et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF STABILIZED 4-HYDROXYIFOSFAMIDE IN HUMAN PLASMA AND ERYTHROCYTES, Journal of chromatography B. Biomedical sciences and applications, 716(1-2), 1998, pp. 275-284
USE OF GRANISETRON IN PATIENTS REFRACTORY TO PREVIOUS TREATMENT WITH ANTIEMETICS
Authors: CARMICHAEL J KEIZER HJ CUPISSOL D MILLIEZ J SCHEIDEL P SCHINDLER AE
Citation: J. Carmichael et al., USE OF GRANISETRON IN PATIENTS REFRACTORY TO PREVIOUS TREATMENT WITH ANTIEMETICS, Anti-cancer drugs, 9(5), 1998, pp. 381-385
CISPLATIN - DNA-ADDUCTS AND PROTEIN-BOUND PLATINUM IN BLOOD OF TESTICULAR CANCER-PATIENTS
Authors: BOFFETTA P FICHTINGERSCHEPMAN AMJ WEIDERPASS E VANDIJKKNIJNENBURG HCM STOTER G VANOOSTEROM AT KEIZER HJ FOSSA SD KALDOR J ROY P
Citation: P. Boffetta et al., CISPLATIN - DNA-ADDUCTS AND PROTEIN-BOUND PLATINUM IN BLOOD OF TESTICULAR CANCER-PATIENTS, Anti-cancer drugs, 9(2), 1998, pp. 125-129
A PHASE I II DOSE-FINDING STUDY OF TOMUDEX(R) (RALTITREXED) AND CISPLATIN IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEAD AND NECK-CANCER/
Authors: HUININK DT DEJONG RJB VERSCHUUR HP KEIZER HJ
Citation: Dt. Huinink et al., A PHASE I II DOSE-FINDING STUDY OF TOMUDEX(R) (RALTITREXED) AND CISPLATIN IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEAD AND NECK-CANCER/, Annals of oncology, 9, 1998, pp. 373-373
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF STABILIZED 4-HYDROXYIFOSFAMIDE IN PLASMA AND ERYTHROCYTES
Authors: KERBUSCH T HUITEMA ADR KEIZER HJ OUWERKERK J DEKRAKER J BEIJNEN JH
Citation: T. Kerbusch et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF STABILIZED 4-HYDROXYIFOSFAMIDE IN PLASMA AND ERYTHROCYTES, Annals of oncology, 9, 1998, pp. 188-188
VALIDITY OF PREDICTIONS OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY INNONSEMINOMATOUS TESTICULAR CANCER
Authors: STEYERBERG EW GERL A FOSSA SD SLEIJFER DT DEWIT R KIRKELS WJ SCHMELLER N CLEMM C HABBEMA JDF KEIZER HJ
Citation: Ew. Steyerberg et al., VALIDITY OF PREDICTIONS OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY INNONSEMINOMATOUS TESTICULAR CANCER, Journal of clinical oncology, 16(1), 1998, pp. 269-274
CHROMATOGRAPHIC ANALYSIS OF THE ENANTIOMERS OF IFOSFAMIDE AND SOME OFITS METABOLITES IN PLASMA AND URINE
Authors: KAIJSER GP BEIJNEN JH BULT A KEIZER HJ UNDERBERG WJM
Citation: Gp. Kaijser et al., CHROMATOGRAPHIC ANALYSIS OF THE ENANTIOMERS OF IFOSFAMIDE AND SOME OFITS METABOLITES IN PLASMA AND URINE, Journal of chromatography B. Biomedical sciences and applications, 690(1-2), 1997, pp. 131-138
POSTCHEMOTHERAPY SURGERY IN NONSEMINOMA
Authors: STEYERBERG EW KEIZER HJ SLEIJFER DT
Citation: Ew. Steyerberg et al., POSTCHEMOTHERAPY SURGERY IN NONSEMINOMA, Journal of clinical oncology, 15(9), 1997, pp. 3165-3166
RESIDUAL MASSES AFTER CHEMOTHERAPY FOR METASTATIC TESTICULAR CANCER -THE CLINICAL IMPLICATIONS OF THE ASSOCIATION BETWEEN RETROPERITONEAL AND PULMONARY HISTOLOGY
Authors: STEYERBERG EW DONOHUE JP GERL A TONER GC KOOPS HS FOSSA SD KEIZER HJ
Citation: Ew. Steyerberg et al., RESIDUAL MASSES AFTER CHEMOTHERAPY FOR METASTATIC TESTICULAR CANCER -THE CLINICAL IMPLICATIONS OF THE ASSOCIATION BETWEEN RETROPERITONEAL AND PULMONARY HISTOLOGY, The Journal of urology, 158(2), 1997, pp. 474-478
RESIDUAL PULMONARY MASSES AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - PREDICTION OF HISTOLOGY
Authors: STEYERBERG EW KEIZER HJ MESSEMER JE TONER GC KOOPS HS FOSSA SD GERL A SLEIJFER DT DONOHUE JP HABBEMA KDF
Citation: Ew. Steyerberg et al., RESIDUAL PULMONARY MASSES AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - PREDICTION OF HISTOLOGY, Cancer, 79(2), 1997, pp. 345-355
LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .6. PHARMACOKINETICS OF THEENANTIOMERS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA, URINE AND CEREBROSPINAL-FLUID
Authors: KAIJSER GP BEIJNEN JH KEIZER HJ DEKRAKER J BULT A UNDERBERG WJM
Citation: Gp. Kaijser et al., LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .6. PHARMACOKINETICS OF THEENANTIOMERS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA, URINE AND CEREBROSPINAL-FLUID, Journal of drug development and clinical practice, 7(4), 1996, pp. 319-326
N7-METHYLGUANINE AND O-6-METHYLGUANINE LEVELS IN DNA OF WHITE BLOOD-CELLS FROM CANCER-PATIENTS TREATED WITH DACARBAZINE
Authors: VANDELFT JHM LUITENSCHUITE A SOULIOTIS VL KYRTOPOULOS SA OUWERKERK J KEIZER HJ BAAN RA
Citation: Jhm. Vandelft et al., N7-METHYLGUANINE AND O-6-METHYLGUANINE LEVELS IN DNA OF WHITE BLOOD-CELLS FROM CANCER-PATIENTS TREATED WITH DACARBAZINE, Biomarkers, 1(2), 1996, pp. 94-98
SURVEILLANCE VERSUS ADJUVANT CHEMOTHERAPY IN STAGE-I NONSEMINOMATOUS TESTICULAR CANCER - A DECISION-ANALYSIS
Authors: STIGGELBOUT AM KIEBERT GM DEHAES JCJM KEIZER HJ STOTER G DEWIT R VERMORKEN JB LEER JWH KIEVIT J
Citation: Am. Stiggelbout et al., SURVEILLANCE VERSUS ADJUVANT CHEMOTHERAPY IN STAGE-I NONSEMINOMATOUS TESTICULAR CANCER - A DECISION-ANALYSIS, European journal of cancer, 32A(13), 1996, pp. 2267-2274
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH CHEMOTHERAPY-RELATED FEBRILE NEUTROPENIA
Authors: VELLENGA E UYLDEGROOT CA DEWIT R KEIZER HJ LOWENBERG B TENHAAFT MA DEWITTE TJM VERHAGEN CAH STOTER GJ RUTTEN FFH MULDER NH SMID WM DEVRIES EGE
Citation: E. Vellenga et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH CHEMOTHERAPY-RELATED FEBRILE NEUTROPENIA, Journal of clinical oncology, 14(2), 1996, pp. 619-627
ISOLATED LIVER PERFUSION WITH MITOMYCIN-C IN THE TREATMENT OF COLORECTAL-CANCER METASTASES CONFINED TO THE LIVER
Authors: MARINELLI A DEBRAUW LM BEERMAN H KEIZER HJ VANBOCKEL JH TJADEN UR VANDEVELDE CJH
Citation: A. Marinelli et al., ISOLATED LIVER PERFUSION WITH MITOMYCIN-C IN THE TREATMENT OF COLORECTAL-CANCER METASTASES CONFINED TO THE LIVER, Japanese Journal of Clinical Oncology, 26(5), 1996, pp. 341-350
PHARMACOKINETICS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA AND URINE OF CANCER-PATIENTS TREATED WITHA 10-DAY CONTINUOUS-INFUSION OF IFOSFAMIDE
Authors: KAIJSER GP KEIZER HJ BEIJNEN JH BULT A UNDERBERG WJM
Citation: Gp. Kaijser et al., PHARMACOKINETICS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA AND URINE OF CANCER-PATIENTS TREATED WITHA 10-DAY CONTINUOUS-INFUSION OF IFOSFAMIDE, Anticancer research, 16(5B), 1996, pp. 3247-3257
LACK OF GLUTATHIONE CONJUGATION OF MELPHALAN IN THE ISOLATED IN-SITU LIVER PERFUSION IN HUMANS
Authors: VAHRMEIJER AL SNEL CAW STEENVOORDEN DPT BEIJNEN JH PANG KS SCHUTRUPS J TIRONA R KEIZER HJ VANDIERENDONCK JH VANDEVELDE CJH MULDER GJ
Citation: Al. Vahrmeijer et al., LACK OF GLUTATHIONE CONJUGATION OF MELPHALAN IN THE ISOLATED IN-SITU LIVER PERFUSION IN HUMANS, Cancer research, 56(20), 1996, pp. 4709-4714
RESECTION OF RESIDUAL RETROPERITONEAL MASSES IN TESTICULAR CANCER - EVALUATION AND IMPROVEMENT OF SELECTION CRITERIA
Authors: STEYERBERG EW KEIZER HJ FOSSA SD SLEIJFER DT BAJORIN DF DONOHUE JP HABBEMA JDF
Citation: Ew. Steyerberg et al., RESECTION OF RESIDUAL RETROPERITONEAL MASSES IN TESTICULAR CANCER - EVALUATION AND IMPROVEMENT OF SELECTION CRITERIA, British Journal of Cancer, 74(9), 1996, pp. 1492-1498
EFFECT OF IFOSFAMIDE TREATMENT ON GLUTATHIONE AND GLUTATHIONE CONJUGATION ACTIVITY IN PATIENTS WITH ADVANCED CANCERS
Authors: MULDERS TMT KEIZER HJ OUWERKERK J VANDERVELDE EA BREIMER DD MULDER GJ
Citation: Tmt. Mulders et al., EFFECT OF IFOSFAMIDE TREATMENT ON GLUTATHIONE AND GLUTATHIONE CONJUGATION ACTIVITY IN PATIENTS WITH ADVANCED CANCERS, Clinical cancer research, 1(12), 1995, pp. 1525-1536
TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA
Authors: CUNNINGHAM D ZALCBERG JR RATH U OLVER I VANCUTSEM E SVENSSON C SEITZ JF HARPER P KERR D PEREZMANGA G AZAB M SEYMOUR L LOWERY K ACKLAND SP BASSER RL CLARKE SJ GOLDSTEIN D GREEN MD GRYGIEL JJ MCKENDRICK JJ MILLWARD MJ OLVER IN TATTERSALL MHN THOMSON DB JAKESZ R BUSET M TUENI EA VANCUTSEM EJD BAUER J BESKA F ADENIS A BRUNET R FRANCOIS E PAILLOT B ROUGIER P FINK UFW KNUTH KRA KOENIG HJ BOHME MWJ WANDER HE AMADORI D FRASSINETI L COCCONI G PASSALACQUA R FRIGERIO F BARNI S LUPORINI G LABIANCA R MARINI G ZANIBONI A KLEPP O TVEIT KM WIST E CANDEIAS OFR GOUVEIA JGP MARQUES JCN OLIVEIRA JML CAVALLI F DELMORE GD GOEDHALS L VOROBIOF DA ESTEVE AAI AGUILAR EA TORRES AA RUIPEREZ AC RUBIO ED SUREDA BM MANGA GP ALFONSO PG GUSTAVSSON B JEPPSON B MALMBERG M STARKHAMMAR H SVENSSON JH KEIZER HJ SCHORNAGEL JH OBRIEN M HARPER PG KERR DJ SCARFFE JH TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
PREDICTION OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - MULTIVARIATE-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 6 STUDY-GROUPS
Authors: STEYERBERG EW KEIZER HJ FOSSA SD SLEIJFER DT TONER GC KOOPS HS MULDERS PFA MESSEMER JE NEY K DONOHUE JP BAJORIN D STOTER G BOSL GJ HABBEMA JDF
Citation: Ew. Steyerberg et al., PREDICTION OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - MULTIVARIATE-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 6 STUDY-GROUPS, Journal of clinical oncology, 13(5), 1995, pp. 1177-1187
IN-VIVO CHARACTERIZATION AND MODULATION OF THE GLUTATHIONE GLUTATHIONE-S-TRANSFERASE SYSTEM IN CANCER-PATIENTS
Authors: MULDERS TMT KEIZER HJ BREIMER DD MULDER GJ
Citation: Tmt. Mulders et al., IN-VIVO CHARACTERIZATION AND MODULATION OF THE GLUTATHIONE GLUTATHIONE-S-TRANSFERASE SYSTEM IN CANCER-PATIENTS, Drug metabolism reviews, 27(1-2), 1995, pp. 191-229
IFOSFAMIDE TREATMENT AS A 10-DAY CONTINUOUS INTRAVENOUS-INFUSION (VOL121, PG 297, 1955)
Authors: KEIZER HJ OUWERKERK J WELVAART K VANDERVELDE CJH CLETON FJ
Citation: Hj. Keizer et al., IFOSFAMIDE TREATMENT AS A 10-DAY CONTINUOUS INTRAVENOUS-INFUSION (VOL121, PG 297, 1955), Journal of cancer research and clinical oncology, 121(8), 1995, pp. 492-492
IFOSFAMIDE TREATMENT AS A 10-DAY CONTINUOUS INTRAVENOUS-INFUSION
Authors: KEIZER HJ OUWERKERK J WELVAART K VANDERVELDE CJH CLETON FJ
Citation: Hj. Keizer et al., IFOSFAMIDE TREATMENT AS A 10-DAY CONTINUOUS INTRAVENOUS-INFUSION, Journal of cancer research and clinical oncology, 121(5), 1995, pp. 297-302
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GM-CSF IN PATIENTS WITH CHEMOTHERAPY-RELATED FEBRILE NEUTROPENIA
Authors: VELLENGA E UYLDEGROOT CA DEWIT R KEIZER HJ LOWENBERG B TENHAAFT MA DEWITTE TJM VERHAGEN CAH STOTER GJ RUTTEN FFH MULDER NH SMID WM DEVRIES EGE
Citation: E. Vellenga et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GM-CSF IN PATIENTS WITH CHEMOTHERAPY-RELATED FEBRILE NEUTROPENIA, Blood, 86(10), 1995, pp. 1990-1990
Risultati: 1-25 | 26-31